| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 03/13/2002 | EP1185553A1 Heart homing peptides and methods of using same |
| 03/13/2002 | EP1185552A1 Retro-inverso peptides derived from interleukin-3 |
| 03/13/2002 | EP1185493A1 Quinones for treatment of diseases |
| 03/13/2002 | EP0721342B1 Polypeptides of the semaphorin gene family |
| 03/13/2002 | CN1340103A Complex-forming proteins |
| 03/13/2002 | CN1340102A Polypeptide variants with raised heparin-binding capacity |
| 03/13/2002 | CN1340057A Synthetic poly peptide disturbing intracelluler signaling |
| 03/12/2002 | US6355805 β3-adrenergic receptor agonists |
| 03/12/2002 | US6355789 Cloned dna sequences related to the entire genomic rna of human immunodeficiency virus ii (hiv-2), polypeptides encoded by these dna sequences and use of these dna clones and polypeptides in diagnostic kits |
| 03/12/2002 | US6355683 Fc receptor modulators and uses thereof |
| 03/12/2002 | US6355619 Chemokines to cognate alpha-chemokine receptors and antitumor agents |
| 03/12/2002 | US6355617 Peptide derivatives |
| 03/12/2002 | US6355613 Cyclized oligopeptides with bridging groups of amide, thioether, thioester or disulfide |
| 03/12/2002 | US6355432 Collection of plurality of beads which have binding polymers of different target specific sequence attached thereto; said beads being coded with encoding system whereby target specific sequence of polymer attached to beads can be identified |
| 03/12/2002 | CA2228091C Preparation used in dental care |
| 03/12/2002 | CA2064077C T cell receptor peptides as therapeutics for autoimmune and malignant disease |
| 03/12/2002 | CA2016235C Labeled chemotactic peptides to image focal sites of infection or inflammation |
| 03/07/2002 | WO2002018437A2 Cyclic peptides having melanocortin-4 receptor agonist activity |
| 03/07/2002 | WO2002018418A1 Antibodies specific for methylated lysines in histones |
| 03/07/2002 | WO2002018417A1 Nucleophile-stable thioester generating compounds, methods of production and use |
| 03/07/2002 | WO2002018369A2 Peptidomimetic protease inhibitors |
| 03/07/2002 | WO2002018341A2 Quinoline- (c=o) - (di-, tri- and tetrapeptide) derivatives as caspase inhibitors |
| 03/07/2002 | WO2002017948A2 Control of crop pests and animal parasites through direct neuronal uptake |
| 03/07/2002 | WO2001058471A3 Novel amino acid and peptide inhibitors of staphylococcus virulence |
| 03/07/2002 | WO2001055177A3 Methods to identify ctl epitopes of hiv |
| 03/07/2002 | WO2001044271A3 Daptomycin analogs and their use as antibacterial agents |
| 03/07/2002 | WO2001043761A3 Methods for treating and preventing damage to mucosal tissue |
| 03/07/2002 | WO2001032692A3 Peptide mimics of conserved gonococcal epitopes and methods and compositions using them |
| 03/07/2002 | WO2001009165A3 ACTIVATION OF PEPTIDE PRODRUGS BY hK2 |
| 03/07/2002 | US20020028916 Purification process |
| 03/07/2002 | US20020028914 Chimeric toxins for targeted therapy |
| 03/07/2002 | US20020028772 Modulation of metabolism |
| 03/07/2002 | US20020028771 Sulfonylation core antibiotic |
| 03/07/2002 | US20020028769 Method for preparing zinc-oligopeptide easily absorbable by the human body |
| 03/07/2002 | US20020028766 Composition of a polypeptide and an amphiphilic compound in an ionic complex and the use thereof |
| 03/07/2002 | US20020028469 Generating monoclonal antibodies |
| 03/07/2002 | US20020028453 Methods and compositions for producing morphogen analogs |
| 03/07/2002 | CA2697205A1 Peptidomimetic protease inhibitors |
| 03/07/2002 | CA2420856A1 Control of crop pests and animal parasites through direct neuronal uptake |
| 03/07/2002 | CA2420667A1 Quinoline-(c=o)-(di-,tri- and tetrapeptide) derivatives as caspase inhibitors |
| 03/07/2002 | CA2420277A1 Antibodies specific for methylated lysines in histones |
| 03/07/2002 | CA2412424A1 Nucleophile-stable thioester generating compounds, methods of production and use |
| 03/06/2002 | EP1183267A1 Retro-inverso peptides derived from interleukin-6 |
| 03/06/2002 | EP1183266A1 Retro-inverso peptides derived from leukemia inhibitory factor |
| 03/06/2002 | EP0723551B1 Hapten-marked peptides |
| 03/06/2002 | CN1338463A Method for improving stability of polypeptide in body and its application |
| 03/06/2002 | CN1080127C Ternary radiopharmaceutical complexes |
| 03/05/2002 | US6353089 Stimulating proliferation of cytotoxic lymphocytes cells by exposing a fluid sample with a major histocompatability complex and incubate to allow lysis of the presenting cells |
| 03/05/2002 | US6352839 Preparing virginiamycins from an engineered microorganisms, having the ability to prevent biosynthesis of the precursor antibiotic; the microorganism is cultured in the presence of a second precursor and the streptogramin analog is recovered |
| 03/05/2002 | US6352824 Redox reversible bipyridyl-osmium complex conjugates |
| 02/28/2002 | WO2002016412A2 Binding polypeptides for b lymphocyte stimulator protein (blys) |
| 02/28/2002 | WO2002016411A2 Binding polypeptides and methods based thereon |
| 02/28/2002 | WO2002015923A1 Orally administered peptides to ameliorate atherosclerosis |
| 02/28/2002 | WO2001085196A3 Cxcr4 antagonist treatment of hematopoietic cells |
| 02/28/2002 | WO2001078767A3 Pharmaceutical preparations comprising modified peptides |
| 02/28/2002 | WO2001076636A3 Pharmaceutical composition of modified pna molecules |
| 02/28/2002 | WO2001038547A3 Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells |
| 02/28/2002 | WO2001027261A3 Conjugates between a peptides and a nucleic acid analog, such as a pna, lna or a morpholino |
| 02/28/2002 | US20020026044 For treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, psoriasis; for wound healing |
| 02/28/2002 | US20020026036 Constructing cassette vector by inserting cDNA coding for heavy chain constant region of human antibody into expression vector for animal cell use, establishing cloning site, digesting cdna coding for heavy chain, inserting into vector |
| 02/28/2002 | US20020026033 Synthetic glycosulfopeptides and methods of synthesis thereof |
| 02/28/2002 | US20020026032 3, 5-Dioxa-12-azawurtzitane compound and process of preparing same |
| 02/28/2002 | US20020025924 Novel lipopeptides as antibacterial agents |
| 02/28/2002 | US20020025918 Polypeptides |
| 02/28/2002 | DE10040700A1 Salze von biologisch aktiven Peptiden, ihre Herstellung und Verwendung Salts of biologically active peptides, their preparation and use |
| 02/28/2002 | DE10040105A1 Peptid- und Peptidmimetika-Derivate mit Integrin-Inhibitor-Eigenschaften Peptide and peptidomimetic derivatives having integrin inhibitor properties |
| 02/28/2002 | DE10040103A1 Peptid- und Peptidmimetika-Derivate mit Integrin-Inhibitor-Eigenschaften II Peptide and peptide derivatives with integrin inhibitor properties II |
| 02/28/2002 | CA2418006A1 Binding polypeptides for b lymphocyte stimulator protein (blys) |
| 02/27/2002 | EP1182213A1 Hybrid enzyme and use thereof |
| 02/27/2002 | EP1181936A1 Synthesis, biological and preclinical evaluation of (D-Phe6,Leu-NHEt13,des-Met14)bombesin(6-14) analogs modified with 1,4,8,11-tetraazaundecane derivatives and labeled with technetium-99m for application in oncology |
| 02/27/2002 | EP1181313A2 Peptides for vaccinating against human cmv |
| 02/27/2002 | EP1181310A1 Chemokine receptor ccr3 antagonists |
| 02/27/2002 | EP1181055A2 Enzyme-activated anti-tumor prodrug compounds |
| 02/27/2002 | CN1337968A Purification of echinocandin cyclopeptide compounds |
| 02/27/2002 | CN1079837C Method for preparing cyclocyto polypeptide A from branched layer wall bacterium |
| 02/26/2002 | US6350854 Isolated 55 to 72 kDa protein which binds to prion proteins |
| 02/26/2002 | US6350572 Interaction between cyclin D1 and steroid receptor coactivators and users thereof in assays |
| 02/26/2002 | US6350430 Melanocortin receptor ligands and methods of using same |
| 02/26/2002 | CA2038030C Synthetic peptides which contain sequences from factor viia, and the use thereof |
| 02/21/2002 | WO2002014867A2 Ultra-sensitive detection systems |
| 02/21/2002 | WO2002014369A2 Human kininogen d5 domain polypeptides and their use |
| 02/21/2002 | WO2002014354A1 Water soluble thiazolyl peptide derivatives |
| 02/21/2002 | WO2002014353A1 Anti-heparin peptides |
| 02/21/2002 | WO2002014352A2 Therapeutic compounds for ovarian cancer |
| 02/21/2002 | WO2002014351A2 α7 NICOTINIC RECEPTOR PEPTIDES AS LIGANDS FOR β AMYLOID P EPTIDES |
| 02/21/2002 | WO2002014350A2 Peptide and peptide mimetic derivatives with integrin inhibitor properties ii |
| 02/21/2002 | WO2002014347A2 Method for producing peptide salts, their use, and pharmaceutical preparations containing these peptide salts |
| 02/21/2002 | WO2002013872A1 Peptide and peptide mimetic conjugates with integrin-inhibitor properties |
| 02/21/2002 | WO2002013775A1 Dental products comprising bone growth enhancing peptide |
| 02/21/2002 | WO2002013763A2 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists |
| 02/21/2002 | WO2001057069A3 Targeting peptides |
| 02/21/2002 | WO2001042277A3 Complementary peptide ligands generated from the human genome |
| 02/21/2002 | WO2000075662A9 Cell-signaling assays |
| 02/21/2002 | US20020022623 A substituted hydroxyethylene compound useful for treating Alzheimer's disease, mild cognitive impairment, Down's syndrome, herediatary cerebral hemmorrhage with amyloidosis, degenerative dementia |
| 02/21/2002 | US20020022595 Treating inflammation resulting from a response of the non-specific defense system in a mammal by administering an antiinflammatory agent and the uncontaminated Mac-1 alpha subunit |
| 02/21/2002 | US20020022033 Diagnosis of Aids |
| 02/21/2002 | CA2419545A1 .alpha.7 nicotinic receptor peptides as ligands for .beta. amyloid peptides |
| 02/21/2002 | CA2419469A1 Derivatives of peptides and peptide mimetics having integrin inhibitor properties ii |
| 02/21/2002 | CA2419159A1 Ultra-sensitive detection systems |
| 02/21/2002 | CA2418303A1 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists |